The outcomes of the Kruskal–Wallis test unveiled a significant correlation between high expression levels of C1orf216 and EEF1E1 (p < 0.05), high expression of SRPRB (p < 0.01), high expression of RABGGTB (p < 0.001), and larger tumor size within the HCC cohort (Fig. 4C). Here, C1orf216 is linked to hepatocellular carcinoma.